Summary of Purpose
To define the benefits and risks associated with warfarin compared with aspirin in a large number of patients followed for a longer period of time (compared to SPAF I) according to age and inherent risk of thromboembolism.Read More →
The following dates are available for this trial. Trial information last updated on 4 September 2008.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- National Institute for Neurological Disorders and Stroke, NIH
Two parallel, randomized, placebo-controlled clinical trials of 1100 patients at 16 U.S. centers. One trial studied patients >75 years of age, the other <=75.